- Lyme disease vaccine shows 70 percent efficacy, Pfizer says The Washington Post
- Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss CNBC
- Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle The Boston Globe
- Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial WSJ
- Pfizer Says Long-Awaited Lyme Vaccine Was Effective in Study Bloomberg.com
